Rtw Investments, Lp

13F Holdings History for Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

Symbol: STOK on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 5.31M shares
Security Ownership: 9.99%

Shares, Excluding Options vs Price

Value, Excluding Options

RTW Investments, LP ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

2025-02-14 - RTW Investments, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.31M shares of Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK). This represents 9.99% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
RTW Investments, LP	9.99%		$37.3M	5.31M			$7.02	13G/A	12/31/2024	14 Feb 2025 09:00:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.83%		$58.2M	5.12M			$11.35	Q2 2025
3/31/2025	0.52%		$34.1M	5.12M			$6.65	Q1 2025
12/31/2024	0.85%	+0.08%	$56.5M	5.12M	+471,240	+10.1%	$11.03	Q4 2024
9/30/2024	0.83%	+0.08%	$57.2M	4.65M	+427,447	+10.1%	$12.29	Q3 2024
6/30/2024	0.88%		$57.1M	4.22M			$13.51	Q2 2024
3/31/2024	0.84%	+0.02%	$57M	4.22M	+93,793	+2.27%	$13.50	Q1 2024
12/31/2023	0.34%	-0.03%	$21.7M	4.13M	-259,513	-5.91%	$5.26	Q4 2023
9/30/2023	0.36%		$17.3M	4.39M			$3.94	Q3 2023
6/30/2023	0.89%		$46.7M	4.39M			$10.63	Q2 2023
3/31/2023	0.76%	+0.09%	$36.6M	4.39M	+519,577	+13.4%	$8.33	Q1 2023
12/31/2022	0.73%	+0.04%	$35.7M	3.87M	+219,158	+6%	$9.23	Q4 2022
9/30/2022	1.08%		$46.9M	3.65M			$12.84	Q3 2022
6/30/2022	1.25%	+0%	$48.2M	3.65M	+7,575	+0.21%	$13.21	Q2 2022
3/31/2022	1.59%		$76.7M	3.64M			$21.05	Q1 2022
12/31/2021	1.28%		$87.4M	3.64M			$23.99	Q4 2021
9/30/2021	1.4%		$92.7M	3.64M			$25.44	Q3 2021
6/30/2021	1.85%		$123M	3.64M			$33.66	Q2 2021
3/31/2021	2.21%	+0.07%	$142M	3.64M	+100,000	+2.82%	$38.84	Q1 2021
12/31/2020	3.68%		$219M	3.54M			$61.93	Q4 2020
9/30/2020	2.86%		$119M	3.54M			$33.49	Q3 2020
6/30/2020	2.38%		$84.5M	3.54M			$23.83	Q2 2020
3/31/2020	3.49%		$81.2M	3.54M			$22.90	Q1 2020
12/31/2019	3.82%	+0.2%	$100M	3.54M	+188,782	+5.63%	$28.32	Q4 2019
9/30/2019	4.13%		$69.4M	3.36M			$20.68	Q3 2019
6/30/2019	4.94%	+4.94%	$92.6M	3.36M	+3,355,466	NEW	$27.59	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.